Original Article

Cancer Screening Prevalence and Preference among Hospitalized Women With and Without Obesity

Authors: Ché Matthew Harris, MD, MS, Regina Kauffman, BS, Waseem Khaliq, MD, MPH


Posted in: Breast Cancer4

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief 2020; 360:1–8.
2. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity N Engl J Med 2019;381:2440–2450.
3. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7–33.
4. Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 2019;92: 121–135.
5. Cohen SS, Palmieri RT, Nyante SJ, et al. Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 2008;112: 1892–1904.
6. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med 2004;19:332–338.
7. Munsell MF, Sprague BL, Berry DA, et al. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev 2014;36:114–136.
8. Liu PH, Wu K, Ng K, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol 2019;5:37–44.
9. Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 2014;32: 3568–3574.
10. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31–54.
11. US Preventive Services Task Force. Breast cancer screening. https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults. Published May 9, 2023. Accessed July 25, 2023.
12. United States Preventive Services Task Force. Final recommendation statement. Colorectal cancer: screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Published May 18, 2021. Accessed January 26, 2023.
13. Ferrante JM, Chen PH, Crabtree BF, et al. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 2007;32:525–531.
14. Maruthur NM, Bolen S, Brancati FL, et al. Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med 2009;24:665–677.
15. Beaber EF, Sprague BL, Tosteson ANA, et al. Multilevel predictors of continued adherence to breast cancer screening among women ages 50– 74 years in a screening population. J Womens Health (Larchmt) 2019;28: 1051–1059.
16. Carlos RC, Fendrick AM, Ellis J, et al. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? J Am Coll Radiol 2004;1:769–776.
17. Carlos RC, Fendrick AM, Patterson SK, et al. Associations in breast and colon cancer screening behavior in women. Acad Radiol 2005;12:451–458.
18. Ferrante JM, Ohman-Strickland P, Hudson SV, et al. Colorectal cancer screening among obese versus non-obese patients in primary care practices. Cancer Detect Prev 2006;30:459–465.
19. US Preventive Services Task Force, ; Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement JAMA 2016;315:2564–2575.
20. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2009;151:716–26, W-236.
21. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879–1886. .
22. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541–1548.
23. Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999; 91:1829–1846.
24. Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358–366.
25. Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007;99:1782–1792.
26. Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011;103:951–961.
27. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373.
28. Susan G. Komen. Breast self-awareness messages. https://www.komen.org/ breast-cancer/screening/self-awareness. Accessed January 2023.
29. National Center for Chronic Disease Prevention and Health Promotion. Breast cancer: what you need to know. https://oklahoma.gov/content/dam/ok/en/health/health2/documents/breast-cancer-fact-sheet.pdf. Accessed January 2023.
30. Alabama FITWAY Colorectal Cancer Program. Colorectal cancer screening. Basic fact sheet. https://www.alabamapublichealth.gov/colon/assets/basic_fact_sheet.pdf. Revised June 2009. Accessed January 2023.
31. Khaliq W, Aamar A, Wright SM. Predictors of non-adherence to breast cancer screening among hospitalized women. PLoS ONE 2015;10:e0145492.
32. Siraj NS, Kauffman R, Khaliq W. Predictors of nonadherence to colorectal cancer screening among hospitalized women. South Med J 2022;115:687–692.
33. Khaliq W, Visvanathan K, Landis R, et al. Breast cancer screening preferences among hospitalized women. J Womens Health (Larchmt) 2013;22:637–642.
34. Graham H, Kauffman R, Khaliq W. Colorectal cancer screening prevalence, perceived barriers, and preference for screening colonoscopy among hospitalized women. Turk J Gastroenterol 2022;33:901–908.
35. Eichholzer M, Richard A, Rohrmann S, et al. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. Eur J Cancer Prev 2016;25:130–136.
36. Seibert RG, Hanchate AD, Berz JP, et al. National disparities in colorectal cancer screening among obese adults. Am J Prev Med 2017;53:e41–e49.
37. Miles RC, Lehman CD, Mercaldo SF, et al. Obesity and breast cancer screening: cross-sectional survey results from the behavioral risk factor surveillance system. Cancer 2019;125:4158–4163.
38. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med 2005;20:989–995.
39. Potter MB, Vu JD, Croughan-Minihane M. Weight management: what patients want from their primary care physicians. J Fam Pract 2001;50: 513–518.
40. Howe EE, Wright SM, Landis R, et al. Addressing obesity in the hospitalized patient: a needs assessment. South Med J 2010;103:500–504.
41. Srivastava G, Johnson ED, Earle RL, et al. Underdocumentation of obesity by medical residents highlights challenges to effective obesity care. Obesity (Silver Spring) 2018;26:1277–1284.
42. Hossain MA, Amin A, Paul A, et al. Recognizing obesity in adult hospitalized patients: a retrospective cohort study assessing rates of documentation and prevalence of obesity. J Clin Med 2018;7:203.
43. Salazar-Sepúlveda LL, Villarreal-Pérez JZ. Impact of diagnosis of overweight and obesity on weight management among hospitalized patients. Obes Res Clin Pract 2019;13:164–167.
44. Bordowitz R, Morland K, Reich D. The use of an electronic medical record to improve documentation and treatment of obesity. Fam Med 2007;39: 274–279.
45. Wachsberg KN, Feinglass J, Williams MV, et al. Willingness for weight loss intervention among overweight and obese inpatients. South Med J 2011;104: 397–400.
46. Harris CM, Rios R, Landis R, et al. Receptivity to weight management interventions among hospitalized obese patients: an untapped opportunity. South Med J 2013;106:337–342.
47. Khaliq W, Landis R, Wright SM. Improving breast cancer screening adherence among hospitalized women. J Womens Health (Larchmt) 2017; 26:1094–1098.
48. Wools A, Dapper EA, de Leeuw JRJ. Colorectal cancer screening participation: a systematic review. Eur J Public Health 2016;26:158–168.
49. Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep 2019;15:100896.
50. Boling W, Laufman L, Lynch GR, et al. Increasing mammography screening through inpatient education. J Cancer Educ 2005;20:247–250.